AI Capsule Endoscopy And Pancreatic Screening Will Transform Long Term Prospects

AnalystHighTarget

Not Invested

Community Contributor

Published

11 Jan 26

Views

n/a

AnalystHighTarget's Fair Value

n/a

24.5%

n/a

24.5%

You can edit this narrative until Jan 12 2:05 AM. Then, changes will post as Updates.

Author's Valuation

US$1450.9% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

Valuator

Company Info

Notes

AnalystHighTarget Fair Value

US$14

50.9% undervalued

Future estimation in

Revenue

Profit Margin

Future PE

Est. Revenue

Forecast revenue growth rate

45.81%

Historical revenue growth rate

N/A

Medical Equipment revenue growth rate

4.31%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.70%

Calculation

US$9.00m

Earnings '29

111.48x

PE Ratio '29

US$1.00b

Market Cap '29

US$1.00b

Market Cap '29

57.38m

No. shares '29

US$17.48

Share Price '29

US$17.48 Share Price '29

Discounted to 2026 @ 7.69% p.a.

US$14.00

Fair Value '26